We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

114 hedge funds and large institutions have $12.6M invested in Sanofi Contingent Value Rights in 2015 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 22 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

3% less funds holding

Funds holding: 117 → 114 (-3)

13% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 16

14% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 22

34% less capital invested

Capital invested by funds: $19.2M → $12.6M (-$6.57M)

Holders
114
Holders Change
-3
Holders Change %
-2.56%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
14
Increased
19
Reduced
22
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$1.97M
2
NGA
New Generation Advisors
Massachusetts
+$861K
3
TL
TowerView LLC
New York
+$99.1K
4
EM
Elliott Management
New York
+$93.7K
5
Millennium Management
Millennium Management
New York
+$70.6K

Top Sellers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
-$714K
2
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$604K
3
Brown Advisory
Brown Advisory
Maryland
-$271K
4
DAM
Deltec Asset Management
New York
-$138K
5
CL
CSS LLC
Illinois
-$90.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
GWM
76
Gupta Wealth Management
California
– -$3K -16,353 Closed
Bank of Montreal
77
Bank of Montreal
Ontario, Canada
– -$772 -5,465 -81%
SIM
78
Sonora Investment Management
Arizona
– -$197 -1,394 -46%
US Bancorp
79
US Bancorp
Minnesota
– -$145 -1,028 -27%
Fifth Third Bancorp
80
Fifth Third Bancorp
Ohio
– -$58 -410 -53%
ACM
81
Argentus Capital Management
Texas
– -$14 -100 Closed
WTC
82
WhitTier Trust Company
Nevada
– -$4 -25 -1%
DPA
83
Delphi Private Advisors
California
– +$1 +4 New
AIA
84
Allegis Investment Advisors
Idaho
– +$3 +20 New
WT
85
Whittier Trust
California
– +$4 +25 +1%
LTFS
86
Ladenburg Thalmann Financial Services
Florida
– +$9 +63 +1%
MFS
87
MSI Financial Services
Massachusetts
– +$21 +151 +52%
MFW
88
Mosaic Family Wealth
Missouri
– +$26 +185 New
AC
89
Alexandria Capital
Virginia
– +$56 +400 New
Creative Planning
90
Creative Planning
Kansas
– +$57 +402 +15%
IA
91
IFP Advisors
Florida
– +$94 +665 New
CP
92
Corbenic Partners
Pennsylvania
– +$114 +804 New
Royal Bank of Canada
93
Royal Bank of Canada
Ontario, Canada
– +$190 +1,345 +70%
RWA
94
Ropes Wealth Advisors
Massachusetts
– +$282 +2,000 New
1 2 3
4

GCVRZ Hedge Fund Activity: Q4 2015 in Review

114 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q4 2015, worth a combined $12.6M — down 34% from $19.2M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of GCVRZ and 14 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 19 added.

The largest buyer was Stonehill Capital Management, adding an estimated $1.97M. The largest seller was Whitebox Advisors, cutting an estimated $714K.

  • 114 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q4 2015, down from 117 in Q3 2015.
  • Funds reported $12.6M of Sanofi Contingent Value Rights stock for Q4 2015, down 34% quarter-over-quarter.
  • 14 funds opened new Sanofi Contingent Value Rights positions in Q4 2015 and 16 closed out, a net change of -2 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q4 2015 was Stonehill Capital Management, an estimated $1.97M added.
  • The largest Sanofi Contingent Value Rights seller in Q4 2015 was Whitebox Advisors, an estimated $714K sold.

Based on aggregated 13F filings for Q4 2015.